Murine leukemia virus (MLV)-based vectors are still the most frequently used gene delivery vehicles, employed in almost 40% of approved clinical protocols worldwide. 1,2 Despite their frequent use as ...

To reduce the time dedicated to clone screening in the development of cell lines for stable virus production, a protocol merging the procedures of cell cloning and titer screening was implemented: the ...

Researchers recently enhanced the titer of a cell line still in development to produce adenovirus viral vectors by 7.5-fold, and without the risk of also producing replication-competent adenoviruses ...

In this article, News-Medical talks to Dr. Ivan Krylov about biosensing and bioprocessing in gene therapy, while also discussing the various products Sartorius produces in order to aid in this.